Clinical Trial Update: Interferon Toxicities in Melanoma Treatment

View source ↗

Summary

The document reports observed toxicities associated with interferon therapy in the treatment of Stage III melanoma, based on a completed clinical trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interferon (interferon)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Stage III Melanoma | Status: COMPLETED